Evidence about the use of naltrexone and for different ways of using it in the treatment of alcoholism

Alcohol and Alcoholism

Volumn 36, Issue 1, 2001, Pages 2-10

  Sinclair, J D ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

NALMEFENE; NALOXONE; NALTREXONE; PLACEBO;

ABSTINENCE; ALCOHOLISM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRINKING BEHAVIOR; DRUG EFFICACY; DRUG SAFETY; HUMAN; MULTICENTER STUDY; OPIATE ADDICTION; PATIENT EDUCATION; PRIORITY JOURNAL; REINFORCEMENT; RELAPSE; REVIEW; TREATMENT INDICATION;

EID: 0035142097     PISSN: 07350414     EISSN: None     Source Type: Journal    
DOI: 10.1093/alcalc/36.1.2     Document Type: Review

References (74)

1. The efficacy of treatment in reducing alcohol consumption: A meta-analysis
2. Naltrexone for alcohol dependence: Double-blind placebo-controlled Finnish trial
3. Alteration of ethanol self-administration by naltrexone
4. Neurobiological approach to alcoholism therapy: The role of naltrexone
5. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: Results of a placebo-controlled trial
6. A randomized 6 month double-blind placebo-controlled study of naltrexone and coping skills education programme
7. Naltrexone and brief counseling to reduce heavy drinking
8. Nicotinic receptor blockade therapy and smoking cessation
9. Ethanol consumption by Fawn-Hooded rats following abstinence: Effect of naltrexone and changes in μ-opioid receptor density
10. The safety profile of naltrexone in the treatment of alcoholism: Results from a multicenter usage study
11. Naloxone interferes with expression of ethanol-induced conditioned place preference
12. Effects of naloxone on limited-access ethanol drinking in rats
13. Naloxone use to eliminate opiate-seeking behavior: Need for extinction of conditioned reinforcement
14. Evidence report/technology assessment: Number 3: Pharmacotherapy for alcohol dependence. Pharmacological treatment of alcohol dependence: A review of the evidence
15. Naltrexone in alcoholism treatment: Patient efficacy and compliance
16. Use of naltrexone in the treatment of alcohol dependence - A double-blind placebo-controlled Finnish trial
17. Targeted naltrexone with coping therapy for controlled drinking, without prior detoxification, is effective and particularly well tolerated: An 8-month controlled trial
18. Central administration of an opiate antagonist decreases oral ethanol self-administration in rats
19. Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats
20. Responding for oral ethanol after naloxone treatment by alcohol-preferring AA rats
21. Effects of continuous opioid receptor blockade on alcohol intake and up-regulation of opioid receptor subtype signaling in a genetic model of high alcohol drinking
22. Effects of naltrexone and ethanol on auditory event-related brain potentials
23. The delta(2)-opioid receptor antagonist naltriben reduces motivated responding for ethanol
24. Effects of chronic treatment with naltrexone on operant self-administration of ethanol in mice
25. Does naloxone suppress self-stimulation by decreasing reward or increasing aversion?
26. Antagonism of the behavioral effects of ethanol by naltrexone in BALB/c C57BL/6, and DBA/2 mice
27. The effect of interrupted alcohol supply on spontaneous alcohol consumption by rhesus monkeys
28. Effect of naltrexone on alcohol consumption during chronic alcohol drinking and after a period of imposed abstinence in free-choice drinking rhesus monkeys
29. Targeted naltrexone treatment of early problem drinkers
30. International update: New findings on promising medications
31. Six-month follow-up of interaction effect between naltrexone and coping skills therapy in outpatient alcoholism treatment
32. Interaction effect between naltrexone and coping skills. Treatment and follow-up data
33. Investigating differences in hospitalized patients detoxified with lorazepam vs. phenobarbital relative to length of stay, average total cost, and use of restraints
34. A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCL for alcohol dependence
35. A double-blind, placebo-controlled study of oral nalmefene for alcohol dependence
36. Naltrexone in the treatment of dually-diagnosed patients
37. Beta-naltrexol level predicts alcohol relapse
38. A controlled trial of naltrexone for alcohol dependence: An Australian perspective
39. Suppression of alcohol preference in high alcohol drinking rats: Efficacy of amperozide versus naltrexone
40. Naltrexone in the treatment of alcohol dependence
41. Naltrexone and coping skills therapy for alcohol dependence
42. Six-month follow-up of naltrexone and psychotherapy for alcohol dependence
43. Suppression of alcohol intake by chronic naloxone treatment in P rats: Tolerance development and elevation of opiate receptor binding
44. Opiate agonists and antagonists discriminated by receptor binding in brain
45. Treatment of heroin-dependent persons with antagonists: Current status altrexone
46. The feasibility of effective psycho-pharmacological treatments for alcoholism
47. Drugs to decrease alcohol drinking
48. The story in Finland behind the new naltrexone treatment for alcoholism (and how I got the patent for it)
49. Laboratory animal research in the discovery and development of the new alcoholism treatment using opioid antagonists
50. Alcoholism: Pharmacological extinction and the P-word
51. Development in Finland of the extinction treatment for alcoholism with naltrexone
52. From optimal complexity to the naltrexone extinction of alcoholism
53. New treatment options for substance abuse from a public health viewpoint
54. Pharmacological extinction of alcohol drinking with opioid antagonists
55. Continued efficacy after naloxone-induced suppression of alcohol drinking: Dependence upon relative timing
56. Morphine-induced suppression of voluntary alcohol drinking in rats
57. The weaning-to-alcohol method for inducing sustained high levels of alcohol consumption: A replication
58. Relating TIQ's, opiates, and ethanol
59. Selective extinction of alcohol drinking in rats with decreasing doses of opioid antagonists
60. Treatment of alcohol dependence with naltrexone utilizing an extinction protocol
61. Extinction of the association between stimuli and drinking in the clinical treatment of alcoholism with naltrexone
62. Long-term follow up of continued naltrexone treatment
63. The effect of naloxone on intragastric ethanol self-administration
64. Opiate antagonists and self-stimulation: Extinction-like response patterns suggest selective reward deficit
65. Naltrexone and the treatment of alcohol dependence: Initial observations
66. Naltrexone in the treatment of alcohol dependence
67. Naltrexone and alcohol dependence: Role of subject compliance
68. The theoretical basis of narcotic addiction treatment with narcotic antagonists
69. Naltrexone reduces ethanol-and/or water-reinforced responding in rhesus monkeys: Effect depends upon ethanol concentration
70. Naltrexone-induced opiate receptor supersensitivity